Dexlansoprazole Capsule, Delayed Release
Product Images NDC 24979-002
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 24979-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Dexlansoprazole 02)
Principal Display Panel (30 mg Capsule Bottle Label)
This is a description of a prescription drug called Dexlansoprazole, which is available in delayed-release capsules. Each capsule contains 30mg of Dexlansoprazole in the form of coated granules. The medication guide should be provided to each patient. The drug should be stored between 20-25°C (68-77°F) with excursions permitted up to 30°C (86°F) and kept in a resistant container. The label includes information about the manufacturer, TW Pharmaceuticals USA Inc., the prescription number (NDC 24979-001-06), the lot number (123488786012), and the expiration date (EXPMVDDYY).*
Principal Display Panel (60 mg Capsule Bottle Label)
NDC 24979-002-06 is a prescription medication in the form of 30 capsules. A medication guide should be dispensed to each patient. The recommended storage temperature is between 20-25°C (68-77°F) with limited excursions permitted between 15-30°C (59-86°F). The manufacturer is identified as "3 ILIJ!!lll!llsll L" and the lot number is 12486780012.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.